Physician profile
Atish D Patel
NPI 1073810990
$17,781.32
in general payments reported to CMS, 2019-2025
12 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.01 · 2020: $35.49 · 2021: $73.02 · 2022: $162 · 2023: $677 · 2024: $1,354 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $2,367 · Travel and Lodging: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,756.25 |
| Food and Beverage | $2,367.04 |
| Travel and Lodging | $325.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $15,081.79 | 2025 | Evoke |
| Abbott Laboratories | $1,296.25 | 2019-2025 | Proclaim, Eterna, Ensite |
| Boston Scientific Corporation | $850.73 | 2024 | Wavewriter Alpha Prime 16, Angiojet Ultra 5000a |
| Vertos Medical, INC. | $124.75 | 2023-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $115.62 | 2022-2024 | Xtampza, Belbuca |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $108.00 | 2020-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $66.78 | 2019-2023 | Xarelto |
| Pacira Therapeutics, INC. | $38.84 | 2021 | |
| Medtronic, INC. | $31.18 | 2025 | Signia |
| Ipsen Biopharmaceuticals, INC | $31.06 | 2024 | Dysport |
| Daiichi Sankyo INC. | $21.57 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.